Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 164 Results

November 18, 2020

Sernova Provides Clinical Update on U.S. Phase I/II Cell Pouch Trial for Type 1 Diabetes

October 30, 2020

Sernova Announces 3-Month Extension of Warrants

October 27, 2020

Sernova to Present at TSX Life Sciences Investor Day

September 24, 2020

Sernova to Present at Virtual BIO Investor Forum

September 22, 2020

Sernova Closes Oversubscribed Private Placement and Accelerates Development Programs

September 10, 2020

Sernova to Participate in Cell and Gene Therapies for Chronic Conditions Panel at the Virtual 2020 Cell & Gene Meeting on the Mesa Conference

September 9, 2020

Sernova Announces Up to $3 Million Private Placement Financing with a Lead Order of $2 Million

August 4, 2020

Sernova Enters into Exclusive Worldwide License Agreement with University of Miami for Therapeutic Cell Immune Protection Technologies

July 16, 2020

Dr. Anke M. Schulte Joins Sernova Global Advisory Board

June 18, 2020

Sernova Highlights Positive Results Presented at the American Diabetes Association s Virtual 80th Scientific Sessions

«...10 111213 14...»

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Corp. All rights reserved.

Scroll to Top